## Why Permanent pacemaker insertion is right The patient has symptomatic sinus bradycardia (rate 42 bpm) with syncope and fatigue, originating from the **sinus node (D)**, indicating sinus node dysfunction or sick sinus syndrome. Per Harrison 21e Ch 247, the KEY indication for permanent pacemaker placement in sinus bradycardia is symptomatic sinus node disease with syncope, fatigue, or exercise intolerance. The combination of symptomatic presentation (syncope, fatigue) and documented sinus bradycardia warrants definitive pacemaker therapy to prevent recurrent syncope and improve quality of life. ## Why each distractor is wrong - **Intravenous atropine 0.5–1 mg stat**: Atropine is appropriate for acute symptomatic bradycardia in emergency settings (e.g., inferior MI with acute SA node ischemia), but this patient has chronic sinus node dysfunction. Atropine provides temporary relief and is not a definitive solution for symptomatic SSS; pacemaker is indicated for long-term management. - **Observation without intervention**: Asymptomatic sinus bradycardia (e.g., in athletes) requires no treatment. However, this patient is symptomatic with syncope—a red flag for syncope recurrence and sudden cardiac events. Observation alone is inappropriate and dangerous. - **Thyroid function tests and treatment if hypothyroid**: While hypothyroidism is a reversible cause of sinus bradycardia, the clinical presentation (syncope, age 68, likely chronic symptoms) and the degree of bradycardia (42 bpm) suggest primary sinus node dysfunction rather than metabolic disease. TSH should be checked as part of workup, but it is not the MOST appropriate next step given the symptomatic presentation. **High-Yield:** Symptomatic sinus bradycardia (syncope, fatigue, exercise intolerance) from sinus node dysfunction = pacemaker; asymptomatic or physiologic bradycardia = observation; acute symptomatic bradycardia = atropine. [cite: Harrison 21e Ch 247]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.